ClinConnect ClinConnect Logo
Search / Trial NCT06888999

In Vitro Exposure by VR to Enhance Return to Work After Sick Leave Due to Stress-related Complaints

Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Mar 20, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Virtual Reality Return To Work Pilot Randomized Controlled Trial Cabin Crew Stress Return To Work Self Efficacy Job Anxiety Usability Return To Work Attitude

ClinConnect Summary

This clinical trial is looking at how virtual reality (VR) can help flight cabin crew members who are on sick leave due to stress-related issues return to work more effectively. The researchers want to find out if using VR can help these individuals get back to their jobs faster, feel more confident about returning, and reduce their anxiety about work. To do this, they will compare two groups: one group will receive standard care from a therapist, while the other group will get that same care plus a session using VR glasses that allow them to experience their workplace in a safe and controlled way.

To participate in this trial, cabin crew members aged 65 to 74 who are currently on sick leave for stress and have been referred by their occupational doctor may be eligible. However, those with certain conditions like epilepsy or specific eye problems, or those who cannot provide signed consent, will not be able to join. If you’re part of the intervention group, you can expect to have a unique experience that may help you feel more prepared and less anxious about returning to work. This study is still in the planning stages and has not started recruiting participants yet.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - sick listed cabin crew with stress-related complaints that are referred by the occupational physician to a specific psychotherapist practice
  • Exclusion Criteria:
  • epilepsy
  • eye condition
  • no signed informed consent

About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)

The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.

Locations

Schiphol, , Netherlands

Patients applied

0 patients applied

Trial Officials

Roosmarijn M.C. Schelvis, PhD

Principal Investigator

Amsterdam UMC

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported